Table of Contents

company-logo

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Aeterna Zentaris Dividend Announcement

• Aeterna Zentaris does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Aeterna Zentaris dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Aeterna Zentaris Dividend History

Aeterna Zentaris Dividend Yield

Aeterna Zentaris current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Aeterna Zentaris stock? Use our calculator to estimate your expected dividend yield:

Aeterna Zentaris Financial Ratios

P/E ratio-0.10
PEG ratio-0.00
P/B ratio0.13
ROE-84.15%
Payout ratio0.00%
Current ratio5.94
Quick ratio5.93
Cash Ratio5.63

Aeterna Zentaris Dividend FAQ

Does Aeterna Zentaris stock pay dividends?
Aeterna Zentaris does not currently pay dividends to its shareholders.
Has Aeterna Zentaris ever paid a dividend?
No, Aeterna Zentaris has no a history of paying dividends to its shareholders. Aeterna Zentaris is not known for its dividend payments.
Why doesn't Aeterna Zentaris pay dividends?
There are several potential reasons why Aeterna Zentaris would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Aeterna Zentaris ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Aeterna Zentaris has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Aeterna Zentaris a dividend aristocrat?
Aeterna Zentaris is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Aeterna Zentaris a dividend king?
Aeterna Zentaris is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Aeterna Zentaris a dividend stock?
No, Aeterna Zentaris is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Aeterna Zentaris stocks?
To buy Aeterna Zentaris you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Aeterna Zentaris stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.